SCHEMBL10184165

SCHEMBL10184165

Cc1nc2ccccc2n1CC(=O)N(c1cccc(F)c1)C1C(=O)N(C2CCCCC2)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 5/20 0.52
▸ PTAFR P25105 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HRH3 Q9Y5N1 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ THRB P10828 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALPL P05186 2/20 0.37
▸ ALPG P10696 2/20 0.37
▸ ALPP P05187 1/20 0.37
▸ PLAA Q9Y263 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ CRHBP P24387 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ CRHR2 Q13324 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183290 0.84 IDH1 (0.50) IDH1SMN1; SMN2TSHRHRH3LMNA
SCHEMBL10185959 0.83 IDH1 (0.52) IDH1THRB
SCHEMBL10183302 0.83 PTAFR (0.41) IDH1PTAFRSMN1; SMN2HRH3ALDH1A1
SCHEMBL10183299 0.82 OPRM1 (0.40) IDH1MAPTLMNAHTT
SCHEMBL10183680 0.81 IDH1 (0.39) IDH1
SCHEMBL10183319 0.81 MEN1 (0.43) IDH1SMN1; SMN2ALDH1A1MAPTLMNA
SCHEMBL10183337 0.81 OPRM1 (0.39) IDH1MAPTLMNAHTT
SCHEMBL10184102 0.81 IDH1 (0.37) IDH1MAPTLMNAPOLB
SCHEMBL10183782 0.80 OPRM1 (0.40) IDH1MAPTLMNA
SCHEMBL10185644 0.80 IDH1 (0.48) IDH1THRBMAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback